Bio-Path Holdings, Inc.
General ticker "BPTH" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $515.8K (TTM average)
Bio-Path Holdings, Inc. does not follow the US Stock Market performance with the rate: -13.4%.
Estimated limits based on current volatility of 5.9%: low 0.07$, high 0.08$
Factors to consider:
- Total employees count: 10 as of 2022
- Top business risk factors: Operational and conduct risks, Capital requirements, Product liability, Cybersecurity threats, Management dependency
- Current price 91.2% below estimated low
- Earnings for 6 months up through Q2 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [0.83$, 2.52$]
- 2025-12-31 to 2026-12-31 estimated range: [0.69$, 2.11$]
Financial Metrics affecting the BPTH estimates:
- Positive: with PPE of -0.2 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -381.51 <= 0.33
- Positive: Inventory ratio change, % of 0 <= 0
- Positive: Investing cash flow per share per price, % of 0 > -0.66
- Negative: negative Industry operating cash flow (median)
- Positive: Industry inventory ratio change (median), % of 0 <= 0
Short-term BPTH quotes
Long-term BPTH plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $13.90MM | $15.84MM | $11.99MM |
| Operating Income | $-13.90MM | $-15.84MM | $-11.99MM |
| Non-Operating Income | $0.03MM | $-0.23MM | $2.10MM |
| R&D Expense | $9.16MM | $11.61MM | $7.29MM |
| Income(Loss) | $-13.87MM | $-16.08MM | $-9.89MM |
| Profit(Loss)* | $-13.84MM | $-16.08MM | $-9.89MM |
| Stockholders Equity | $14.17MM | $0.44MM | $0.15MM |
| Assets | $15.97MM | $3.22MM | $3.88MM |
| Operating Cash Flow | $-15.10MM | $-11.54MM | $-10.57MM |
| Capital expenditure | $0.02MM | $0.00MM | $0.00MM |
| Investing Cash Flow | $-0.02MM | $0.00MM | $0.00MM |
| Financing Cash Flow | $1.73MM | $2.20MM | $10.70MM |
| Earnings Per Share** | $-38.03 | $-33.64 | $-4.12 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.